Logo image of CLA.PA

CLARANOVA SE (CLA.PA) Stock Fundamental Analysis

Europe - EPA:CLA - FR0013426004 - Common Stock

1.57 EUR
+0.02 (+1.29%)
Last: 11/10/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CLA. CLA was compared to 111 industry peers in the Software industry. There are concerns on the financial health of CLA while its profitability can be described as average. CLA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CLA had negative earnings in the past year.
In the past year CLA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
Each year in the past 5 years CLA had a positive operating cash flow.
CLA.PA Yearly Net Income VS EBIT VS OCF VS FCFCLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

CLA has a Return On Assets of -1.14%. This is in the lower half of the industry: CLA underperforms 62.16% of its industry peers.
CLA had an Average Return On Invested Capital over the past 3 years of 17.26%. This is above the industry average of 12.66%.
The last Return On Invested Capital (%ROIC%%) for CLA is well below the 3 year average (17.26%), which needs to be investigated, but indicates that CLA had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
CLA.PA Yearly ROA, ROE, ROICCLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

CLA's Operating Margin of 8.86% is in line compared to the rest of the industry. CLA outperforms 59.46% of its industry peers.
CLA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 29.19%, CLA is doing worse than 78.38% of the companies in the same industry.
In the last couple of years the Gross Margin of CLA has grown nicely.
Industry RankSector Rank
OM 8.86%
PM (TTM) N/A
GM 29.19%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
CLA.PA Yearly Profit, Operating, Gross MarginsCLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLA is creating value.
The number of shares outstanding for CLA has been increased compared to 1 year ago.
Compared to 5 years ago, CLA has more shares outstanding
Compared to 1 year ago, CLA has an improved debt to assets ratio.
CLA.PA Yearly Shares OutstandingCLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLA.PA Yearly Total Debt VS Total AssetsCLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.60, we must say that CLA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.60, CLA is not doing good in the industry: 80.18% of the companies in the same industry are doing better.
The Debt to FCF ratio of CLA is 5.38, which is a neutral value as it means it would take CLA, 5.38 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.38, CLA is in line with its industry, outperforming 54.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Altman-Z 0.6
ROIC/WACCN/A
WACC7.58%
CLA.PA Yearly LT Debt VS Equity VS FCFCLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

CLA has a Current Ratio of 0.50. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
CLA has a worse Current ratio (0.50) than 87.39% of its industry peers.
CLA has a Quick Ratio of 0.50. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
CLA has a Quick ratio of 0.45. This is amonst the worse of the industry: CLA underperforms 88.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.45
CLA.PA Yearly Current Assets VS Current LiabilitesCLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

CLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.81%, which is quite impressive.
Looking at the last year, CLA shows a decrease in Revenue. The Revenue has decreased by -0.95% in the last year.
CLA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.58% yearly.
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%

3.2 Future

The Earnings Per Share is expected to grow by 23.66% on average over the next years. This is a very strong growth
Based on estimates for the next years, CLA will show a very negative growth in Revenue. The Revenue will decrease by -36.90% on average per year.
EPS Next Y1.82%
EPS Next 2Y19.6%
EPS Next 3Y23.66%
EPS Next 5YN/A
Revenue Next Year-38.74%
Revenue Next 2Y-51.27%
Revenue Next 3Y-36.9%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLA.PA Yearly Revenue VS EstimatesCLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CLA.PA Yearly EPS VS EstimatesCLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

5

4. Valuation

4.1 Price/Earnings Ratio

CLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 7.90, which indicates a rather cheap valuation of CLA.
CLA's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLA is cheaper than 95.50% of the companies in the same industry.
CLA is valuated cheaply when we compare the Price/Forward Earnings ratio to 33.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 7.9
CLA.PA Price Earnings VS Forward Price EarningsCLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLA is valued cheaply inside the industry as 99.10% of the companies are valued more expensively.
CLA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CLA is cheaper than 99.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.98
EV/EBITDA 2.77
CLA.PA Per share dataCLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CLA's earnings are expected to grow with 23.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.6%
EPS Next 3Y23.66%

0

5. Dividend

5.1 Amount

CLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (11/10/2025, 7:00:00 PM)

1.57

+0.02 (+1.29%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)11-13 2025-11-13
Inst Owners5.58%
Inst Owner ChangeN/A
Ins Owners5.02%
Ins Owner ChangeN/A
Market Cap89.82M
Revenue(TTM)488.60M
Net Income(TTM)-3.30M
Analysts80
Price Target3.26 (107.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.67%
EPS NY rev (3m)-46.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)163.64%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.9
P/S 0.18
P/FCF 2.98
P/OCF 2.43
P/B N/A
P/tB N/A
EV/EBITDA 2.77
EPS(TTM)-0.08
EYN/A
EPS(NY)0.2
Fwd EY12.65%
FCF(TTM)0.53
FCFY33.51%
OCF(TTM)0.64
OCFY41.08%
SpS8.54
BVpS-0.3
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE N/A
ROCE -2165%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.86%
PM (TTM) N/A
GM 29.19%
FCFM 6.16%
ROA(3y)-4.27%
ROA(5y)-1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.26%
ROIC(5y)13.84%
ROICexc(3y)46.34%
ROICexc(5y)36.95%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.49%
ROCE(5y)18.83%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y3.39%
ROICexc growth 5Y10.18%
OM growth 3Y14.65%
OM growth 5Y11.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.23%
GM growth 5Y1.62%
F-Score7
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.38
Debt/EBITDA 0.21
Cap/Depr 55.74%
Cap/Sales 1.39%
Interest Coverage 250
Cash Conversion 66.49%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.45
Altman-Z 0.6
F-Score7
WACC7.58%
ROIC/WACCN/A
Cap/Depr(3y)51.75%
Cap/Depr(5y)41.72%
Cap/Sales(3y)1.22%
Cap/Sales(5y)0.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.85%
EPS Next Y1.82%
EPS Next 2Y19.6%
EPS Next 3Y23.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y1.74%
Revenue growth 5Y13.58%
Sales Q2Q%-2.36%
Revenue Next Year-38.74%
Revenue Next 2Y-51.27%
Revenue Next 3Y-36.9%
Revenue Next 5YN/A
EBIT growth 1Y22.32%
EBIT growth 3Y16.65%
EBIT growth 5Y26.75%
EBIT Next Year-30.02%
EBIT Next 3Y-5.72%
EBIT Next 5YN/A
FCF growth 1Y323.94%
FCF growth 3Y32.3%
FCF growth 5Y48.99%
OCF growth 1Y212.71%
OCF growth 3Y28.52%
OCF growth 5Y40.7%

CLARANOVA SE / CLA.PA FAQ

Can you provide the ChartMill fundamental rating for CLARANOVA SE?

ChartMill assigns a fundamental rating of 3 / 10 to CLA.PA.


What is the valuation status of CLARANOVA SE (CLA.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CLARANOVA SE (CLA.PA). This can be considered as Fairly Valued.


How profitable is CLARANOVA SE (CLA.PA) stock?

CLARANOVA SE (CLA.PA) has a profitability rating of 4 / 10.


How financially healthy is CLARANOVA SE?

The financial health rating of CLARANOVA SE (CLA.PA) is 2 / 10.